GlaxoSmithKline
GSK
#213
Rank
โ‚ฌ83.17 B
Marketcap
41,18ย โ‚ฌ
Share price
1.50%
Change (1 day)
24.86%
Change (1 year)

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ3.81 Billion

According to GlaxoSmithKline's latest financial reports the company has โ‚ฌ3.81 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ4.47 B-22.15%
2023-12-31โ‚ฌ5.75 B-33.55%
2022-12-31โ‚ฌ8.65 B75.68%
2021-12-31โ‚ฌ4.92 B-27.92%
2020-12-31โ‚ฌ6.83 B27.37%
2019-12-31โ‚ฌ5.36 B22.23%
2018-12-31โ‚ฌ4.39 B-0.31%
2017-12-31โ‚ฌ4.40 B-24.68%
2016-12-31โ‚ฌ5.84 B-26.92%
2015-12-31โ‚ฌ8.00 B41.86%
2014-12-31โ‚ฌ5.64 B-15.66%
2013-12-31โ‚ฌ6.68 B28.35%
2012-12-31โ‚ฌ5.21 B-26.17%
2011-12-31โ‚ฌ7.05 B-2.54%
2010-12-31โ‚ฌ7.24 B-7.62%
2009-12-31โ‚ฌ7.84 B8.87%
2008-12-31โ‚ฌ7.20 B16.68%
2007-12-31โ‚ฌ6.17 B36.83%
2006-12-31โ‚ฌ4.51 B-40.78%
2005-12-31โ‚ฌ7.61 B35.32%
2004-12-31โ‚ฌ5.62 B14.81%
2003-12-31โ‚ฌ4.90 B29.46%
2002-12-31โ‚ฌ3.78 B-0.63%
2001-12-31โ‚ฌ3.81 B-33.03%
2000-12-31โ‚ฌ5.69 B80.27%
1999-12-31โ‚ฌ3.15 B19.52%
1998-12-31โ‚ฌ2.64 B14.81%
1997-12-31โ‚ฌ2.30 B26.34%
1996-12-31โ‚ฌ1.82 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
โ‚ฌ7.02 B 84.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ12.85 B 237.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ15.63 B 309.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ8.37 B 119.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ8.96 B 135.17%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.89 B-50.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.55 B-85.42%๐Ÿ‡บ๐Ÿ‡ธ USA